Recent studies indicate that high expression of PKM2 synergizes with PD-L1 to predict worse survival in human lung adenocarcinoma, while WSX1 downregulation is closely correlated with poor prognosis in HCC. The gene discussed is CD274; the disease is hepatocellular carcinoma.